Evaluation of vancomycin individualized model-based dosing approach in neonates.

Abouelkheir, Manal; Almohaizeie, Abdullah; Almutairi, Abdulrahman; Almuhisen, Sara; Alqahtani, Saeed; Alsultan, Abdullah

Abouelkheir, Manal; Almohaizeie, Abdullah; Almutairi, Abdulrahman; Almuhisen, Sara; Alqahtani, Saeed; Alsultan, Abdullah.

Afiliação

Abouelkheir M; Department of Clinical Pharmacy, College of Pharmacy, Misr International University, Cairo, Egypt.
Almohaizeie A; Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Almutairi A; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Department of Pharmaceutical Care, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Almuhisen S; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.
Alqahtani S; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alsultan A; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Electronic address: absultan@ksu.edu.sa.

Pediatr Neonatol ; 64(3): 327-334, 2023 05.

Article em En | MEDLINE | ID: mdl-36581523

Assuntos

Antibacterianos; Vancomicina; Recém-Nascido; Humanos; Vancomicina/farmacocinética; Estudos Retrospectivos

Palavras-chave

Neonates; Pharmacodynamics; Pharmacokinetics; Vancomycin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vancomicina / Antibacterianos Tipo de estudo: Guideline Limite: Humans / Newborn Idioma: En Revista: Pediatr Neonatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google